Rasagiline Tablets

Award Notice Posted

Solicitation number
SPE2D2-26-D-0011
Agency
Awarded
to Golden State Medical Supply, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
SPE2D2-26-D-0011 Federal IDV award
Place of performance
Delran, New Jersey 08075, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Defense Logistics Agency (DLA) Troop Support Medical awarded contract SPE2D2-26-D-0011 to Golden State Medical Supply, Inc. on April 2, 2026, for the supply of pharmaceutical products valued at $6,637,357.21 over a five-year period. The contract covers the provision of Rasagiline tablets in two formulations—0.5 MG and 1 MG—supplied in 30-count bottles, with base year unit pricing of $19.53 and $34.39 respectively, with modest price increases scheduled for option years. Golden State Medical Supply will serve as the distributor for products manufactured by Carnegie Pharmaceuticals, LLC, with packaging and packing operations occurring at facilities in both Delran, New Jersey and Camarillo, California. Payment will be processed through the DLA Pharmaceutical Prime Vendor program, and the contract is subject to applicable federal acquisition regulations governing commercial items and services.

Notice text

SPE2D2-26-D-0011 Rasagiline Tablets Award

Awarded contract SPE2D2-26-D-0011 to GOLDEN STATE MEDICAL SUPPLY, INC. for 6637357.21 on 2026-04-02.

Files

Notice history

Notice Type Posted
This notice Latest Award Notice
Pharm Manuf/Distr Div - FSA Award Notice
Rasagiline Tablets Latest solicitation Solicitation
Rasagiline Tablets Original Pre-Solicitation

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity